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Scedosporium species: the rising importance of newly 
emerging fungal pathogens 
Scedosporium refers to a family of fungi which cause 
infections s d a r  in te rm of diversity and severity 
to those caused by Aspergillus, and mycetomas. Two 
species of Scedosporium are medically sigtllficant: Scedo- 
sporium apiospermum (first identified in 1909 b m  a 
mycetoma) and Scedosporium pro l f iam (isolated &om a 
bone biopsy in 1984). 
These pathogens are more fiequently detected, and 
only their isolation in culture confirms the diagnosis; 
other methods are not reliable. The low sensitivity of 
the fungus to presently available antifUngal agents 
account for the serious prognosis of such infections. 
Epidemiology 
Scedospon'um species are saprophpc agents isolated b m  
many natural substrates (soils, potted plants, polluted 
water). The geographic distribution of mycetomas 
shows a predomination in temperate and sub-tropical 
areas. Other types of infections have been observed 
worldwide [ 11. 
To conform to taxonomists' recommendations, the 
name of the sexual state Pseudalleschetia boydii has to be 
preferentially used rather than Scedosporium apiospermum 
(but no sexual state has been discovered for Scedospon'um 
prollficans). 
Clinical manifestations 
Clinical aspects differ according to the species, the 
route of contamination and the immune status of the 
host (Table 1). 
Table 1 Clinical aspects of Scedosporium infections 
Scedosporium Sudosporium 
apiospenum (l? boydii) prollficanr 
Through direct Mycetoma (presence Localized infections 
inoculation of white grains) +++ (osteomyelitis++) 
Localized infections 
Through Simple pulmonary Simple pulmonary 
inhalation colonization colonization 
Allergic broncho- Invasive pulmonary 
pulmonary disease disease (and metastatic 
Inwive pulmonary lesions) 
disease (and metastatic 
lesions] 
Scedosporium apiospemum (Pseudallescheria boydii) 
In t h s  case, direct inoculations (through a trauma 
wound or a wound puncture) are reported, causing 
mycetomas (cutaneous and subcutaneous lesions pro- 
ducing white grains). 
To a lesser degree, localized infections are described 
(orbit, cutaneous and subcutaneous tissues, brain, 
joints, bone): they are usually called pseudallescheriasis 
(not mycetoma) because of the lack of grains [2]. 
Mycetomas and localized infections are observed in 
previously normal hosts, but the latter may also be 
observed during metastatic dissemination of the fungus 
during an invasive process. 
Aerial contamination may lead to invasive pul- 
monary disease in immunosuppressed patients, often 
followed by spread to other areas of the body because 
of the angioinvasive nature of the fungus [3]. Invasive 
disease with l? boydii is described in the normal host, 
following submersion in polluted water. 
A simple endobronchal or pulmonary coloniza- 
tion may be seen in adults over 40 years of age with 
pre-existing disease (such as bronchiectasis or tuber- 
culosis), and in farmers. These cases of colonization are 
difficult to differentiate fiom lung invasion. Allergic 
bronchopulmonary disease due to I? boydii has been 
described in patients with asthma or previous allergic 
bronchopulmonary aspergdlosis. 
Scedosporium pmlificans 
Almost all infections with S. prolificam followed a 
penetrating trauma wound and remain localized [4]. 
It usually causes osteomyelitis, but other sites may be 
infected. Disseminated infections have been described 
in neutropenic patients. Although rare, an increasing 
number of such cases have been observed. 
Little is known about the host factors control- 
ling immunity in the course of scedosporiosis, but 
N o t e s  a n d  Comments 5 
numerous cases have been reported in corticosteroid- 
treated patients, or in leukemic or transplanted patients. 
Few cases have been described in acquired immuno- 
deficiency syndrome [5]. 
Laboratory diagnosis 
Few techques are avdable and reliable. The optimal 
one is to inoculate clinical specimens (biopsy, broncho- 
alveolar lavage) on Sabouraud agar:a rapid growth 
( w i h  1-2 weeks) of a f lue  white to dark colony is 
observed. On nutritionally poor media, cleistothecia 
(representing the sexual state) may be observed as 
brown, s m a l l  and round structures embedded among 
the hyphae. Because Pseudallescheria boydii is ubiquitously 
present, the pathogen must be repeatedly isolated from 
the site of infection before it can be considered to be 
pathogenic. 
Histopathologic analysis of tissue sections cannot 
differentiate septate hyphae of I? boydii from other 
morphologically similar hyaline hyphomycetes (e.g. 
molds which grow in tissue as light-colored and septate 
hyphal elements without pigment in their cell wds: 
Aspergillus, Penicilliurn, Fusariurn). Histologic studies on 
experimental I? boydii infections show a polymorpho- 
nuclear cell infiltrate surrounding hyphae and conidia 
and the absence of macrophages. 
Serologic diagnosis of pseudallescheriasis is not 
standardized at the present time, and results are merent  
according to the method employed. An antibody res- 
ponse is sometimes detected in the course of a simple 
lung colonization, and only few patients with proven 
pseudallescheriasis have been found to produce humoral 
antibodies. These serological tests are therefore not 
very helpful in differentiating infection and simple 
colonization [6]. 
Medical treatment 
The distinction between the two species is not only a 
taxonomic problem, but also constitutes an essential 
therapeutic problem. Although S. apiospermurn is in 
vitro moderately unresponsive to amphotericin B 
and ketoconazole, and sensitive to miconazole and 
itraconazole, S. prolificans is very resistant to all forms 
of antifungal therapy. However, these susceptibility 
criteria are based on in vitro data and not on accurate 
observations of clinical outcome. When possible, a 
combination of chemotherapy and surgery seems the 
best approach. However, recovery fi-om disseminated 
Scedosporiurn infections seems to be due more to the 
improvement of the underlying disease (neutropenia) 
than to the anfingal agents. 
Scedosporiurn species are emerging pathogens which 
will probably be seen more in the future because of 
the increasing number of immunosuppressed patients. 
The greatest dititiculty is to a simple colonization h m  
a true infection: the pathogenicity of each isolate has to 
be debated between clinicians and microbiologists. 
Figure 1 Scedosporium is microscopically characterized by annellidic conidia that are produced terminally or laterally on 
hyphae, which may be grouped in coremia. 
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